IDEAYA Biosciences (IDYA) Earnings Analysis

IDEAYA Biosciences (IDYA) has no confirmed upcoming earnings date. Last quarter (2026-02-17) it beat with EPS -0.94 USD vs -0.95172 USD est (+1.2%). It has beaten estimates in 2/3 recent quarters (67%). Trailing P/E -22.15.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does IDYA next report earnings?

No confirmed upcoming earnings date is currently scheduled for IDYA. This page updates as the calendar is published.

IDYA earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-17-0.94 USD-0.95172 USD+1.2%Beat
2025-02-13-1.49 USD-0.67 USD-122.4%Miss
2024-11-04-0.6 USD-0.67 USD+10.4%Beat

Beat rate: 2/3 (67%) over reported quarters with consensus data.

IDYA valuation and analyst view

Trailing P/E-22.15
Trailing EPS-1.57902 USD
Price / book3.31
Dividend yield0.00%
Market cap3.36B
Analyst consensusBuy (23 buy / 2 hold / 0 sell)
Avg price target55.5 USD

Related research pages

Frequently asked questions

When is IDEAYA Biosciences (IDYA)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for IDYA. This page updates as the calendar is published.

Did IDYA beat earnings last quarter?

In its 2026-02-17 report, IDYA posted EPS of -0.94 USD versus a -0.95172 USD estimate — a beat of 1.2%.

What is IDYA's earnings track record?

Over the last 3 reported quarters with consensus data, IDYA beat estimates 2 times (67%).

What is IDYA's current P/E ratio and EPS?

IDYA trades at a trailing P/E of -22.15 on trailing EPS of -1.5790235449807448 USD.

What do analysts rate IDYA?

Analyst consensus is "Buy" across 25 ratings (0 strong buy, 23 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 55.5 USD.